Literature DB >> 21352747

No coexistence for free: neutral null models for multistrain pathogens.

Marc Lipsitch1, Caroline Colijn, Ted Cohen, William P Hanage, Christophe Fraser.   

Abstract

In most pathogens, multiple strains are maintained within host populations. Quantifying the mechanisms underlying strain coexistence would aid public health planning and improve understanding of disease dynamics. We argue that mathematical models of strain coexistence, when applied to indistinguishable strains, should meet criteria for both ecological neutrality and population genetic neutrality. We show that closed clonal transmission models which can be written in an "ancestor-tracing" form that meets the former criterion will also satisfy the latter. Neutral models can be a parsimonious starting point for studying mechanisms of strain coexistence; implications for past and future studies are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 21352747      PMCID: PMC3099423          DOI: 10.1016/j.epidem.2008.07.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  49 in total

Review 1.  Exploring the evolution of diversity in pathogen populations.

Authors:  S Gupta; M C Maiden
Journal:  Trends Microbiol       Date:  2001-04       Impact factor: 17.079

2.  Ecological interference between fatal diseases.

Authors:  P Rohani; C J Green; N B Mantilla-Beniers; B T Grenfell
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

Review 3.  The causes and consequences of HIV evolution.

Authors:  Andrew Rambaut; David Posada; Keith A Crandall; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2004-01       Impact factor: 53.242

4.  Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.

Authors:  Eugene V Millar; Katherine L O'Brien; James P Watt; Melinda A Bronsdon; Jean Dallas; Cynthia G Whitney; Raymond Reid; Mathuram Santosham
Journal:  Clin Infect Dis       Date:  2006-05-18       Impact factor: 9.079

5.  Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland.

Authors:  William P Hanage; Tarja H Kaijalainen; Ritva K Syrjänen; Kari Auranen; Maija Leinonen; P Helena Mäkelä; Brian G Spratt
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 6.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

7.  Carriage of pneumococci after pneumococcal vaccination.

Authors:  S K Obaro; R A Adegbola; W A Banya; B M Greenwood
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

8.  Evolution of virulence: a unified framework for coinfection and superinfection.

Authors:  J Mosquera; F R Adler
Journal:  J Theor Biol       Date:  1998-12-07       Impact factor: 2.691

9.  Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria.

Authors:  S Gupta; J Swinton; R M Anderson
Journal:  Proc Biol Sci       Date:  1994-06-22       Impact factor: 5.349

Review 10.  Unifying the epidemiological and evolutionary dynamics of pathogens.

Authors:  Bryan T Grenfell; Oliver G Pybus; Julia R Gog; James L N Wood; Janet M Daly; Jenny A Mumford; Edward C Holmes
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

View more
  52 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Superinfection and the evolution of resistance to antimalarial drugs.

Authors:  Eili Y Klein; David L Smith; Ramanan Laxminarayan; Simon Levin
Journal:  Proc Biol Sci       Date:  2012-07-11       Impact factor: 5.349

Review 3.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

4.  Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.

Authors:  Marc Lipsitch; Osman Abdullahi; Alexander DʼAmour; Wen Xie; Daniel M Weinberger; Eric Tchetgen Tchetgen; J Anthony G Scott
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

5.  Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.

Authors:  Sarah Cobey; Marc Lipsitch
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

6.  Within-host parasite cooperation and the evolution of virulence.

Authors:  Samuel Alizon; Sébastien Lion
Journal:  Proc Biol Sci       Date:  2011-05-11       Impact factor: 5.349

7.  Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage.

Authors:  Sonja Lehtinen; François Blanquart; Nicholas J Croucher; Paul Turner; Marc Lipsitch; Christophe Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

8.  Impact of Antimicrobial Treatment for Acute Otitis Media on Carriage Dynamics of Penicillin-Susceptible and Penicillin-Nonsusceptible Streptococcus pneumoniae.

Authors:  Joseph A Lewnard; Paula A Tähtinen; Miia K Laine; Laura Lindholm; Jari Jalava; Pentti Huovinen; Marc Lipsitch; Aino Ruohola
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

9.  Virus dynamics in the presence of synaptic transmission.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Math Biosci       Date:  2013-01-25       Impact factor: 2.144

10.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

Authors:  Caroline Colijn; Ted Cohen; Christophe Fraser; William Hanage; Edward Goldstein; Noga Givon-Lavi; Ron Dagan; Marc Lipsitch
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.